Free Trial

Tissue Regenix Group (TRX) Competitors

Tissue Regenix Group logo
GBX 29.80 +0.80 (+2.76%)
As of 11:35 AM Eastern

TRX vs. SFR, NAK, EGI, IMG, EDG, MTA, NGR, RRS, NG, and WPM

Should you be buying Tissue Regenix Group stock or one of its competitors? The main competitors of Tissue Regenix Group include Severfield (SFR), Nakama Group plc (NAK.L) (NAK), (EGI.L) (EGI), 532753 (IMG.L) (IMG), 651814 (EDG.L) (EDG), ArcelorMittal (MTA), Nature Group (NGR), Randgold Resources (RRS), National Grid (NG), and Wheaton Precious Metals (WPM). These companies are all part of the "precious metals" industry.

Tissue Regenix Group vs. Its Competitors

Tissue Regenix Group (LON:TRX) and Severfield (LON:SFR) are both small-cap precious metals companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Severfield has a net margin of 3.43% compared to Tissue Regenix Group's net margin of -3.46%. Severfield's return on equity of 7.24% beat Tissue Regenix Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Tissue Regenix Group-3.46% -2.87% 0.50%
Severfield 3.43%7.24%4.69%

37.0% of Tissue Regenix Group shares are owned by institutional investors. Comparatively, 66.9% of Severfield shares are owned by institutional investors. 47.3% of Tissue Regenix Group shares are owned by company insiders. Comparatively, 4.4% of Severfield shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Severfield has higher revenue and earnings than Tissue Regenix Group. Tissue Regenix Group is trading at a lower price-to-earnings ratio than Severfield, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tissue Regenix Group£31.98M0.84-£1.11M-£0.97-30.77
Severfield£444.13M0.21£15.24M£5.256.04

Tissue Regenix Group has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500. Comparatively, Severfield has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500.

In the previous week, Severfield had 1 more articles in the media than Tissue Regenix Group. MarketBeat recorded 1 mentions for Severfield and 0 mentions for Tissue Regenix Group. Severfield's average media sentiment score of 0.53 beat Tissue Regenix Group's score of 0.00 indicating that Severfield is being referred to more favorably in the news media.

Company Overall Sentiment
Tissue Regenix Group Neutral
Severfield Positive

Summary

Severfield beats Tissue Regenix Group on 10 of the 13 factors compared between the two stocks.

Get Tissue Regenix Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRX vs. The Competition

MetricTissue Regenix GroupBiotechnology IndustryMedical SectorLON Exchange
Market Cap£26.87M£137.09M£5.82B£3.22B
Dividend Yield4.12%3.74%3.84%5.04%
P/E Ratio-30.773.8731.15164.63
Price / Sales0.844,053.59475.15310,107.36
Price / Cash5.7013.1937.1527.93
Price / Book0.7246.309.115.90
Net Income-£1.11M-£90.99M£3.26B£5.89B
7 Day Performance-0.67%0.61%2.11%48.33%
1 Month Performance-19.46%3.58%5.12%49.98%
1 Year Performance-51.94%197.78%31.25%127.65%

Tissue Regenix Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRX
Tissue Regenix Group
N/AGBX 29.80
+2.8%
N/A-53.6%£26.87M£31.98M-30.77120Gap Up
SFR
Severfield
N/AGBX 32.30
+1.6%
N/A-61.0%£94.32M£444.13M6.151,900Dividend Cut
Gap Up
NAK
Nakama Group plc (NAK.L)
N/AN/AN/AN/A£1.44M£8.09M-6.1353Gap Down
High Trading Volume
EGI
(EGI.L)
N/AN/AN/AN/A£0.00N/A0.006Gap Down
High Trading Volume
IMG
532753 (IMG.L)
N/AN/AN/AN/A£0.00N/A0.005,360High Trading Volume
EDG
651814 (EDG.L)
N/AN/AN/AN/A£0.00N/A0.002,610
MTA
ArcelorMittal
N/AN/AN/AN/A£0.00N/A0.009High Trading Volume
NGR
Nature Group
N/AN/AN/AN/A£0.00N/A0.0010Gap Up
RRS
Randgold Resources
N/AN/AN/AN/A£0.00N/A0.0021,300Gap Up
NG
National Grid
1.3367 of 5 stars
GBX 1,060.50
+1.9%
GBX 1,135
+7.0%
+7.2%£52.07B£25.99B17.4210High Trading Volume
WPM
Wheaton Precious Metals
2.2726 of 5 stars
GBX 7,075.68
+0.2%
GBX 7,800
+10.2%
+50.5%£39.73B£1.51B65.1942Positive News

Related Companies and Tools


This page (LON:TRX) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners